1. Home
  2. NEPH vs TOI Comparison

NEPH vs TOI Comparison

Compare NEPH & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.93

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.64

Market Cap

346.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
TOI
Founded
1997
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.0M
346.3M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
NEPH
TOI
Price
$4.93
$3.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$6.00
AVG Volume (30 Days)
58.2K
1.6M
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$17,930,000.00
$461,039,000.00
Revenue This Year
$33.32
$28.51
Revenue Next Year
$12.27
$23.54
P/E Ratio
$35.51
N/A
Revenue Growth
32.36
21.67
52 Week Low
$1.39
$0.21
52 Week High
$6.42
$4.88

Technical Indicators

Market Signals
Indicator
NEPH
TOI
Relative Strength Index (RSI) 48.86 54.74
Support Level $4.65 $3.23
Resistance Level $5.34 $3.90
Average True Range (ATR) 0.39 0.23
MACD -0.02 0.03
Stochastic Oscillator 40.46 65.10

Price Performance

Historical Comparison
NEPH
TOI

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: